Clinical Trial Update: Efficacy and Safety of Precision Therapy in Refractory Tumor [Phase 2]

View source ↗

Summary

Phase 2 trial update on a precision therapy showing efficacy and safety in refractory tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rare Tumor
• Tumor

Drugs mentioned

• Precision Therapy

Snippet

Sponsor: Baodong Qin | Conditions: Rare Tumor, Refractory Tumor | Phase 2 | Status: UNKNOWN